The influence of the microenvironment on the malignant phenotype

Molecular Medicine Today

Volumn 6, Issue 8, 2000, Pages 324-329

  Park, Catherine C ^a   Bissell, Mina J ^b   Barcellos Hoff, Mary Helen ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c Materials Sciences Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; CARCINOGENESIS; CELL FUNCTION; CYTOARCHITECTURE; EXTRACELLULAR MATRIX; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PHENOTYPE; REVIEW;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; INTEGRINS; NEOPLASMS; PHENOTYPE; RADIATION, IONIZING; TRANSFORMING GROWTH FACTOR BETA; WOUNDS AND INJURIES;

EID: 0034254445     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(00)01756-1     Document Type: Review

References (46)

1. Ronnov-Jessen L. Stromal reaction to invasive cancer: the cellular origin of the myofibroblast and implications for tumor development. Breast J. 2:1996;320-339.
2. Bissell M.J.et al. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 59:1999;1757s-1763s. discussion 1763s-1764s.
3. van den Hoof A. Stromal involvement in malignant growth. Adv. Cancer Res. 50:1988;159-196.
4. Barcellos-Hoff M.H. The potential influence of radiation-induced microenvironments in neoplastic progression. J. Mam. Gland Bio. Neoplasia. 3:1998;165-175.
5. Lukashev M.E., Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 8:1998;437-441.
6. Farber E. The multistep nature of cancer development. Cancer Res. 44:1984;4217-4223.
7. Weinberg R.A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Canc. Res. 49:1989;3713-3721.
8. Kim S.H.et al. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J. Cell Biol. 123:1993;877-893.
9. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
10. Kinzler K.W., Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 386:1997;761-763.
11. Kinzler K.W., Vogelstein B. Landscaping the cancer terrain. Science. 280:1998;1036-1037.
12. Bissell M.J. The differentiated state of normal and malignant cells or how to define a 'normal' cell in culture. Int. Rev. Cytol. 70:1981;27-100.
13. Bissell M.J., Barcellos-Hoff M.H. The influence of extracellular matrix on gene expression: is structure the message? J. Cell Sci. 8:1987;327-343.
14. Pierce G.B.et al. Cancer: A Problem of Developmental Biology. 1978;Prentice-Hall, Englewood Cliffs, NJ, USA.
15. Hynes R.O. Integrins: a family of cell surface receptors. Cell. 48:1987;549-554.
16. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science. 238:1987;491-497.
17. Anderson E.et al. Estrogen responsiveness and control of normal human breast proliferation. J. Mam. Gland Biol. Neoplasia. 3:1998;23-35.
18. Munger J.et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:1999;319-328.
19. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv. Cancer Res. 76:1999;1-20.
20. Weaver V.M.et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:1997;231-245.
21. Roberts A.B.et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U. S. A. 83:1986;4167-4171.
22. Cui W.et al. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev. 9:1995;945-955.
23. Taipale J.et al. Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv. Cancer Res. 75:1998;87-134.
24. Barcellos-Hoff M.H. Latency and activation in the regulation of TGF-β J. Mam. Gland Biol. Neoplasia. 3:1996;353-363.
25. Reiss M., Barcellos-Hoff M.H. Transforming growth factor-β in breast cancer: a working hypothesis. Br. Cancer Res. Treat. 45:1997;81-95.
26. Fynan T.M., Reiss M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncog. 4:1993;493-540.
27. Pitot H.C., Dragan Y.P. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J. 5:1991;2280-2286.
28. Little J.B. Radiation carcinogenesis. Carcinogenesis. 21:2000;397-404.
29. Trosko, J. E. et al. (1990) Modulation of intercellular communication during radiation and chemical carcinogenesis. 123, 241-251.
30. Bauer G. Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol. Histopathol. 11:1996;237-255.
31. Barcellos-Hoff, M.H. and Ravani, S.A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. (in press).
32. Fisher B., Fisher E.R. Role of host and tumor calcium in metastases. Cancer Res. 28:1968;1753-1758.
33. Sieweke M.H., Bissell M.J. The tumor promoting effect of wounding: a possible role for TGF-β induced fibrotic stroma. Crit. Rev. Oncog. 5:1994;297-311.
34. Furstenberger G.et al. Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int. J. Cancer. 43:1989;915-921.
35. Moses H.L.et al. Transforming growth factor β regulation of cell proliferation. J. Cell. Phys. Suppl. 5:1987;1-7.
36. Akhurst R.J.et al. Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature. 331:1988;363-365.
37. Cui W.et al. TGFβ 1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 86:1996;531-542.
38. Portella G.et al. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9:1998;393-404.
39. Folkman J. Addressing tumor blood vessels. Nat. Biotechnol. 15:1997;510.
40. Danø K.et al. Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS. 107:1999;120-127.
41. Gordon M.Y.et al. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature. 328:1987;342-344.
42. Xu X.C.et al. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J. Natl. Cancer Inst. 91:1999;1317-1321.
43. Bhatia R.et al. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. J. Clin. Invest. 94:1994;384-391.
44. Bhatia R.et al. Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha. J. Clin. Invest. 96:1995;931-939.
45. Briand P.et al. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium in vitro. Cell Dev. Biol. 23:1987;181-188.
46. Petersen O.W.et al. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;9064-9068.